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Hyponatremia in the 2009 161-km Western States Endurance Run
Abstract

Purpose:To determine the incidence of exercise-associated hyponatremia (EAH), the associated biochemical
measurements and risk factors for EAH, and whether there is an association between postrace blood sodium
concentration ([Na+]) and changes in body mass among participants in the 2009 Western States Endurance
Run, a 161-km mountain trail run.
Methods: Change in body mass, postrace [Na+], and blood creatine phosphokinase (CPK) concentration, and
selected runner characteristics were evaluated among consenting competitors.
Results: Of the 47 study participants, 14 (30%) had EAH as defined by a postrace [Na+] /L. Postrace [Na+]
and percent change in body mass were directly related (r = .30, P = .044), and 50% of those with EAH had
body mass losses of 3–6%. EAH was unrelated to age, sex, finish time, or use of nonsteroidal antiinflammatory drugs during the run, but those with EAH had completed a smaller (P = .03) number of
161-km ultramarathons. The relationship of CPK levels to postrace [Na+] did not reach statistical significance
(r = –.25, P = .097).
Conclusions: EAH was common (30%) among finishers of this 161-km ultramarathon and it was not unusual
for those with EAH to be dehydrated. As such, changes in body mass should not be relied upon in the
assessment for EAH during 161-km ultramarathons.
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Hyponatremia in the
2009 161-km Western States Endurance Run
Martin D. Hoffman, Kristin J. Stuempfle, Ian R. Rogers,
Louise B. Weschler, and Tamara Hew-Butler
Purpose: To determine the incidence of exercise-associated hyponatremia (EAH), the associated biochemical
measurements and risk factors for EAH, and whether there is an association between postrace blood sodium
concentration ([Na+]) and changes in body mass among participants in the 2009 Western States Endurance
Run, a 161-km mountain trail run. Methods: Change in body mass, postrace [Na+], and blood creatine phosphokinase (CPK) concentration, and selected runner characteristics were evaluated among consenting competitors. Results: Of the 47 study participants, 14 (30%) had EAH as defined by a postrace [Na+] <135 mmol/L.
Postrace [Na+] and percent change in body mass were directly related (r = .30, P = .044), and 50% of those
with EAH had body mass losses of 3–6%. EAH was unrelated to age, sex, finish time, or use of nonsteroidal
anti-inflammatory drugs during the run, but those with EAH had completed a smaller (P = .03) number of
161-km ultramarathons. The relationship of CPK levels to postrace [Na+] did not reach statistical significance
(r = –.25, P = .097). Conclusions: EAH was common (30%) among finishers of this 161-km ultramarathon
and it was not unusual for those with EAH to be dehydrated. As such, changes in body mass should not be
relied upon in the assessment for EAH during 161-km ultramarathons.
Keywords: dehydration, endurance exercise, exercise, sodium, water–electrolyte imbalance
The development of exercise-associated hyponatremia (EAH; blood sodium concentration of <135 mmol/L)
appeared to be an unusual consequence of endurance
exercise when first described in non-peer-reviewed magazines in the early 1980s1,2 and the scientific literature in
1985.3 Since these initial descriptions, at least nine deaths
from EAH have been confirmed and this potentially fatal
medical condition has been found to be common in a
variety of endurance activities.4 For instance, the incidence of EAH has been observed to be as high as 18%
in Ironman triathlons,5 13% in standard marathons (42
km),6,7 and 12% in an endurance cycling event,8 but as
low as 0–0.6% in other ultraendurance events.9–11
In our recent work, we saw an alarmingly high EAH
incidence of 51% during a 161-km trail ultramarathon
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that was run under hot conditions.12 That study also noted
that 57% (12 of 21) of the hyponatremic finishers had lost
>3% of their body mass. This was in contrast to previous
studies, mostly from shorter duration competitions, in
which EAH was relatively rare in subjects who had lost
that much body mass.6,13–16 Further work to clarify the
incidence of hyponatremia with such levels of weight
loss is of critical importance because runners presenting
for medical attention with >3% body mass loss would
typically be treated with aggressive rehydration. Such
treatment in the presence of hyponatremia could be fatal.
The present study examined the incidence of hyponatremia in a 161-km ultramarathon run to determine if
the high incidence of EAH we previously observed in
such an event12 would be replicated. We also wished to
determine whether change in body mass was related to
EAH occurrence, and whether EAH would again prove to
be common among those with weight loss.12 Finally, we
sought to discover whether select runner characteristics
were related to the development of EAH. Since previously reported risk factors for EAH have included female
sex, slow performance, event inexperience, and use of
nonsteroidal anti-inflammatory drugs (NSAIDs) during
the event,17 we examined these variables. Because there
has been suggestion of an association between EAH and
rhabdomyolysis,18–21 we also examined postrace blood
creatine phosphokinase (CPK) concentrations.
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Methods
The study was performed at the 2009 Western States
100-Mile (161-km) Endurance Run (WSER), in Northern
California. The course is almost entirely on single track
mountain trails with 5500 m of cumulative climb and
7000 m of cumulative descent. Twenty-four aid stations
were stocked with various fluids, nutritional items, and
salt capsules. Body mass was measured at nine of these
stations during the race, and race policy was to force
rest and rehydration for competitors whose body mass
loss was >5% compared with their registration mass.
Participants had 30 h to complete the race. Nearby ambient temperature ranged from 4°C to 37°C.
Institutional Review Board approval was granted
for this study and subjects provided informed consent.
Subjects were recruited via prerace emails and during
race registration the day before the race. Body mass
was measured with a weight scale (WW42D impedance
scale, Weight Watchers, New York City, NY) positioned
on a solid level surface during race registration with
the subjects barefoot and wearing lightweight running
clothes. Within a few minutes of finishing the race,
barefoot body mass was measured with the same scale
on a solid level surface, and blood was drawn from an
antecubital vein for onsite analysis of sodium concentration ([Na+]) using an I-Stat portable analyzer (Abbott,
Princeton, NJ). The I-Stat has been reported to have a
coefficient of variation of ≤0.01% in the measurement
of [Na+] and to yield a strong correlation (r = .95) with
the Ciba Corning 288 blood gas analyzer for [Na+].22
Blood was also sent to the local hospital laboratory for
determination of blood CPK concentration. Creatine
phosphokinase values over 40,000 U/L were not diluted
for further analysis and were reported as >40,000.
Each subject was sent an e-mail the day following
the race with an invitation to complete an electronic
survey. Details of the methods and findings of the survey

are provided elsewhere.23,24 Select questions used in the
present study were those determining whether nausea
had affected race performance, if NSAIDs were used
during the race, the greatest distance run in one week
during the 3 mo before the race, and the number of
prior 161-km running races completed. The latter was
determined from our records25,26 for those runners not
completing the postrace survey. Finish times and subject
ages were obtained from official race results.
Unpaired t tests and Fisher’s exact tests were used
to compare hyponatremic and normonatremic runners in
interval and categorical variables, respectively. A nonparametric Mann-Whitney test was used to analyze the
number of previously completed 161-km races because
these data were not normally distributed. Pearson correlation analyses were used to examine the associations
between interval variables after verifying the values
approximated Gaussian distributions. A value of 40,000
was used in the analyses for CPK values >40,000. Statistical significance was set at P < .05.

Results
A total of 104 of the 399 race starters consented to participate in the study. Of those, 47 finished the race and
provided blood samples upon completing the race, and
14 (30%) of this group had a [Na+] below 135 mmol/L.
All were fully oriented and without evidence of altered
mental status.
Table 1 compares characteristics of normonatremic
and hyponatremic groups. The two groups were not
statistically different with regard to age, sex, finish time,
highest training distance week, presence of nausea during
the race, and use of NSAIDs during the race. Those who
were normonatremic had a greater (P = .03) number of
previous 161-km race finishes. Normonatremics also
had trends (P = .06) toward less weight loss and lower
postrace CPK concentrations than hyponatremic runners.

Table 1 Comparison of normonatremic and hyponatremic groups. Data are presented as mean ±
SD except where indicated. The last three items are based upon survey responses from 35 of the
47 study participants.
Item

Normonatremic

Hyponatremic

P value

Postrace [Na+] (mmol/L)

138.3 ± 2.4

131.5 ± 2.2

<0.0001

Age (years)

44.6 ± 7.0

42.0 ± 9.6

0.30

Women (%)

18.2

28.6

0.46

Finish Time (hours)

25.84 ± 2.73

26.29 ± 2.80

0.61

Change (postrace minus registration) in Body Mass (%)

–1.0 ± 2.6

–2.6 ± 2.5

0.06

Postrace CPK (U/L)

19,018 ± 13,467

27,518 ± 13,571

0.06

161-km Races Previously Completed (Median and Range)

3 (range 0–56)

1 (range 0–43)

0.03

Highest Running Distance in 1 Week (km)

139 ± 39

134 ± 44

0.73

Presence of Nausea (%)

43.5

58.3

0.49

Use of NSAIDs (%)

56.5

58.3

1.00
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Postrace [Na+] was positively and significantly
related to percent change in body mass (Figure 1). Also
notably evident from this figure is that 7 of the 14 hyponatremic runners lost 3–6% of body mass.
Finish time was unrelated to percent change in body
mass (Figure 2). The greatest decrease in body mass
(6.3%) was seen for the fastest study participant.
Creatine phosphokinase concentrations were unrelated to percent change in body mass (r = .08, P = .60)
or to postrace [Na+] (Figure 3).

Discussion
The most important findings of this study are that
there was a direct relationship between postrace [Na+]
and percent change in body mass, and that half of the
hyponatremic runners had lost >3% body mass during
the race. These findings contrast with previous studies
in which postrace [Na+] has universally been found to
be inversely related to change in body mass.6,9,13–16,27
Furthermore, a compilation of data from 2,135 finishes
of different endurance events that were mostly shorter in
duration than that of the present study demonstrated that
the incidence of EAH was only 4% among those who lost
>3% body mass.15 This contrasts with the present study in
which EAH was present among 54% of those with >3%
body mass loss. Yet, the current findings are consistent
with those of Lebus et al12 and confirm that EAH can be
relatively common during a 161-km ultramarathon when
body mass loss is >3%. Furthermore, even if we were to
consider a mass loss of 4% as the minimum required for
dehydration, which would be appropriate based upon
our energy balance data from this event,28 we would
conclude that 50% (5 of 10) of the runners with such
mass loss had EAH.
Another important finding of the present study was
the high incidence of EAH. The 30% incidence of EAH
in the present study was considerably higher than the 7%
incidence in the compilation study.15 Furthermore, a comparable study of 13 finishers of a hot (21–38°C) 160-km
ultramarathon run reported that none were hyponatremic
at the finish.9 Yet interestingly, our current findings are
consistent with the high incidence (51%) reported by
Lebus et al12 during a 161-km ultramarathon, which, like
the ultramarathon of the present study, took place under
hot conditions in northern California on a challenging
trail course. The reason for the apparently unique findings
from these 161-km ultramarathons in northern California
is not clear and invites further exploration.
Overhydration from excessive fluid intake is considered to be an important etiology of EAH.15,17 Considering
overhydration as a lack of mass loss,15 34% of the present
sample was found to be overhydrated. Yet, of those who
overhydrated, only two (13%) developed biochemical
EAH, and none developed clinically significant EAH.
This differs considerably from the compilation study in
which overhydration was present among only 11% of
subjects, of which 11% and 19% developed biochemical
EAH and clinically significant EAH respectively, for a
total of 30% of those who were overhydrated developing

Figure 1 — Relationship of postrace [Na+] to percent change
(postrace minus registration) in body mass.

Figure 2 — Relationships of finish time to percent change
(postrace minus registration) in body mass.

Figure 3 — Relationships of CPK to postrace [Na+].

EAH. Furthermore, 45% of those with EAH were overhydrated in the compilation study, whereas only 14% of
those with EAH were overhydrated in the present study.
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Thus, overhydration was more common in the present
study, yet was not as likely to be associated with EAH as
in the compilation study.
The high incidence of an increase in body mass in the
present event probably relates to the emphasis on avoidance of significant mass loss. Race policy at the time of
the event required that runners be stopped and rehydrated
for mass loss of >5%. The high incidence of an increase
in body mass may also relate to a great emphasis in the
United States on the use of sodium supplementation during
endurance competitions. In fact, the WSER Participant’s
Guide recommends sodium intake, and sodium capsules
were provided at aid stations. Excessive sodium intake is
likely to result in plasma volume expansion and gain in
body mass.12,29 But, it is interesting that overhydration was
less likely to be associated with EAH in this study compared with others. The fact that most of the runners in the
overhydrated group were normonatremic is consistent with
the premise that excessive fluid intake was accompanied
by aggressive sodium intake.
Previous work has concluded that sodium supplementation via salt capsules is unnecessary to maintain [Na+]
during prolonged endurance exercise.14,29 However, the
high incidence of EAH in 161-km ultramarathons observed
in the present study and that of Lebus and colleagues,12
along with the finding that EAH can commonly be associated with dehydration suggests that sodium loss may be
an etiological factor in the development of EAH during
these longer duration events under high ambient temperatures. Alternatively, the osmotic inactivation of circulating
sodium or failure to adequately mobilize osmotically inactive sodium from internal stores have been suggested as
underlying etiologies of EAH.15 Further work is required to
fully illuminate the relative role of these potential mechanism in EAH under the conditions of this event.
The present study examined other risk factors for
EAH. Previously reported risk factors for EAH include
female sex, slow performance, event inexperience, and
use of NSAIDs during the event.17 The present work found
no statistical evidence for EAH being related to age, sex,
race performance, or use of NSAIDs. However, this work
does support higher risk associated with fewer previous
event completions.
Nonosmotic secretion of arginine vasopressin is felt to
be an exacerbating factor in most cases of EAH.17 Nausea
is a potential nonosmotic stimulus for arginine vasopressin
secretion. While about half the subjects reported nausea,
there was no difference in the frequency of nausea between
those who presented with EAH and those who did not.
Recent case reports have suggested a link between
rhabdomyolysis and EAH.18–21 Theoretically, EAH could
promote rhabdomyolysis through changes in intracellular
potassium or calcium concentrations, or through hypotonic
extracellular fluid being drawn into the muscle cell, each of
which could reduce the stability of the cell membrane and
allow for easier breakdown. Conversely, the breakdown of
muscle cells could lead to third spacing of fluids, which
could stimulate arginine vasopressin secretion leading
to EAH. The present study examined CPK levels, and
although statistical differences between hyponatremic

and normonatremic groups were not found (P = .06), the
data suggest that closer examination with a larger subject
sample is warranted.
This study examined only postrace [Na+] rather than
prerace to postrace change in [Na+], as has been the case
for some studies.9,27,30 We believe that postrace [Na+] is
the more relevant measure and likely to be more reflective of any change in [Na+] from normal baseline under
the conditions of this study. The WSER weighing policy
has engendered a culture in which runners try to weighin light at registration. They typically weigh-in in the
morning before eating on the day before the race so that
the value is lower than it would be the next morning after
aggressively hydrating during the remaining hours before
the race. This practice may cause a transient lowering of
prerace [Na+] that would not accurately reflect the normal
baseline value for these individuals. For the same reason,
we believe that our use of body mass measurements at
registration the day before the event is more reflective of
a normal baseline than measurements made immediately
prerace. Previous work has demonstrated that body mass
immediately before the start of an endurance competition
is 0.6–1.05 kg higher than at race registration11,31–33 supporting the premise that such measurements may reflect
an overhydrated state rather than a normal baseline. As
such, our use of body mass measurements from registration
would tend to underestimate mass loss during the event
relative to what would be determined based upon prerace
measurements. This means that the proportion of runners
with EAH who had >3% mass loss would likely have been
even higher than 50% had we used body mass measurements from immediately before the race. Regardless, the
reality is that the registration weight is the value used by
race officials, and so this value has the greatest practical
importance in this race.
The lowest postrace [Na+] we observed was 126
mmol/L. In fact, only this one case was in the “clinically
significant” range (<128.9 mmol/L) as defined by Noakes
et al.15 Furthermore, none of our cases displayed evidence
of hyponatremic encephalopathy. Yet, asymptomatic EAH
can rapidly progress to severe illness.17 Thus, further investigation into the underlying mechanism and the explanation
for the high incidence of EAH in 161-km ultramarathons
is warranted.
The high incidence of EAH we have observed during
hot weather 161-km ultramarathons makes it imperative
that on-site and local emergency medical personnel be
cognizant that some runners seeking medical attention
are likely to be hyponatremic. In addition, EAH can occur
with considerable loss in body mass during a hot 161-km
ultramarathon indicating that changes in body mass cannot
be relied upon in the clinical assessment for EAH. As such,
the need for onsite [Na+] analysis, as recommended by the
EAH Consensus Group,17 is justified. Furthermore, encouragement of oral hypotonic fluids or the administration of
intravenous hypotonic fluids, even in athletes who present
as fluid depleted, is risky without knowing the [Na+].
In summary, this work demonstrates that EAH can be
common (30% incidence) among finishers at a hot 161-km
run and that it may not be unusual for those with EAH to
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be dehydrated. The development of EAH was unrelated
to age, sex, finish time, or use of NSAIDs during the run,
but those developing EAH had completed fewer 161-km
ultramarathons.
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